Mexico vs Netherlands: HIV-positive TB patients on ART (antiretroviral therapy)
Mexico
66.0%
in 2023
Netherlands
61.0%
in 2022
Mexico rank
132nd
Netherlands rank
135th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Mexico
- Netherlands
How they compare
Mexico currently reports 66.0% against 61.0% in Netherlands, a difference of 5.0%.
That makes Mexico's figure about 1.1 times Netherlands's.
The two have swapped places 4 times across 9 shared years of data; in 2007 it was Netherlands ahead.
Mexico ranks 132nd and Netherlands ranks 135th of 144 countries.
Across the 3 decades both report, Mexico averaged higher in 1 and Netherlands in 2.
Head to head by decade
| Decade | Mexico | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 27.5% | 100.0% | 72.5% | Netherlands |
| 2010s | 75.8% | 63.2% | 12.5% | Mexico |
| 2020s | 64.3% | 72.3% | 8.0% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Mexico or Netherlands?
- Mexico, at 66.0% against 61.0% in Netherlands as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Mexico and Netherlands?
- 5.0%, with Mexico ahead.
- How many years of comparable data are there for Mexico and Netherlands?
- 9 years are reported by both, from 2007 to 2022.
- How do Mexico and Netherlands rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Mexico ranks 132nd and Netherlands ranks 135th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.